AdvancedEducational map · not a treatment protocol

Weight Loss Plateau Breakthrough

Tesamorelin VAT label versus off-label secretagogue folklore. Visceral fat that “refuses to burn” is not a research-chem indication.

Duration

8-12 weeks

First reports

3-6 weeks

SKUs on this map

3

1Overview

Egrifta (tesamorelin) VAT reduction is the HIV-lipodystrophy label. Laundering that onto a research cake or a general plateau is marketing. AOD-9604 missed primary endpoints in late-stage obesity work. MOTS-c is AMPK mechanism, not a whoosh protocol.

Ideal Candidates

✓Individuals who have lost significant weight but are stuck on the last 10-15 lbs
✓Those suffering from "skinny fat" syndrome (low body weight but high visceral fat)
✓Patients experiencing metabolic slow-down from prolonged caloric deficits

Contraindications

✕Active malignancies or history of cancer
✕Uncontrolled diabetes or severe insulin resistance

2The Science

Prolonged deficit lowers expenditure. That is physiology. Tesamorelin is a GHRH analog labeled for HIV-associated VAT. AOD-9604 is a modified 176–191 fragment with a failed late-stage obesity program. MOTS-c is mitochondrial signaling. None of these "commands" a plateau to end.

3The Peptide Stack

TE

Tesamorelin

View Profile →

FDA-approved as Egrifta for HIV-associated lipodystrophy VAT. That file is not a general-population cut protocol.

Mechanism: GHRH analog. Pulsatile GH. VAT reduction in the labeled HIV-lipodystrophy population. Glucose watching still applies.

Half-life: ~26-38 minutesDose range: 1-2 mg/day
AO

The specific fragment of the Human Growth Hormone molecule that is responsible for fat burning, without the insulin-resistance side effects of full HGH.

Mechanism: Stimulates lipolysis (breakdown of fat) and inhibits lipogenesis (transformation of non-fat food materials into body fat).

Half-life: ~30 minutes (estimated)Dose range: 300-500 mcg/day
MO

Addresses the actual root cause of the plateau: mitochondrial inefficiency and metabolic downregulation from long-term dieting.

Mechanism: Acts as an exercise-mimetic, upregulating AMPK pathways to drastically improve insulin sensitivity and mitochondrial oxidation.

Half-life: ~4-6 hours (estimated)Dose range: 5-10 mg/week

4Protocol Tiers

The Advanced Plateau Breaker

Three SKUs people stack on a stall. Independent mechanisms on paper. Not a labeled combination and not a whoosh guarantee.

Duration
8-12 weeks
Frequency: Daily to Weekly
Timing: Upon waking, fasted. Must wait 60 minutes before eating carbohydrates.
Clinical Note: Extremely potent. Monitor for joint swelling (water retention).
AOD-9604300 mcg
Timing: Administered mid-day, fasted, prior to cardiovascular exercise.
Clinical Note: Highly synergistic with fasted Zone 2 cardio and injectable L-Carnitine.
MOTS-c5 mg
Timing: Once a week, ideally sub-q roughly 30 minutes before intense exercise.
Clinical Note: Restores the metabolic engine to allow Tesamorelin/AOD to work effectively.

5Lifestyle Integration

Lifestyle notes that travel with these SKUs. Not a prescription and not required for the math to be valid.

Training

Fasted Zone 2 cardiovascular exercise (heart rate 120-135 bpm) for 45-60 minutes immediately following AOD-9604/L-Carnitine administration.

Nutrition

Supplement Stack: L-Carnitine (preferably injectable) to ferry the mobilized fat into the mitochondria. Berberine or Metformin to maintain rock-bottom insulin levels throughout the day. Diet breaks or "refeeds" (1-2 weeks at maintenance calories) may profoundly assist this protocol.

Sleep

Critical for cortisol management. High cortisol directly binds visceral fat and refuses to let it oxidize.

Stress Management

Psychological stress from the "plateau" often drives cortisol up. Step off the scale and focus on visual/measurement changes.

6Timeline & Expectations

Weeks 1-3

What You'll NoticePossible slight weight *increase* on the scale due to intracellular water retention from Tesamorelin. Clothes will begin to feel looser around the waist.
What's Happening BiologicallyGH levels are rising systemically. Water is being pulled into muscle cells while fat cells begin to empty their lipid contents.

Weeks 4-8

What You'll NoticeGH-axis water can raise the scale. Waist change, if any, is not proof you chemically overrode adaptation.
What's Happening BiologicallySustained lipolysis is outpacing lipogenesis. The metabolic adaptation has been chemically overridden.

7Monitoring & Safety

Key Metrics to Track

Waist CircumferenceThe absolute best metric for this protocol. Measure at the navel perfectly horizontal.
Fasting Blood GlucoseEnsure Tesamorelin is not driving up insulin resistance.

Troubleshooting

Scale is going up instead of down
Possible Causes
  • Water retention from GH surge
  • Gaining lean mass while losing fat
Solutions
  • Ignore the scale for 3 weeks. Drink 1+ gallons of water daily and closely monitor your waistline measurement instead.